Dimethicone (CAS 63148-62-9), also known as polydimethylsiloxane or PDMS, is a linear silicone polymer built on a repeating –(CH₃)₂SiO– backbone capped with trimethylsiloxy groups. It is a clear, colourless, odourless fluid supplied across a viscosity range that spans from water-thin 20 cSt fluids to gum-like materials above 1,000,000 cSt. That single molecular platform delivers a combination of properties that organic polymers struggle to match simultaneously: low surface tension, thermal and oxidative stability, optical clarity, physiological inertness, and the ability to form breathable, non-greasy films. The consequence is that dimethicone is not a single-application specialty; it is a formulation platform that sits at the centre of personal care, pharmaceutical excipients, industrial release and lubrication, electronic protection and textile finishing. Market sizing reflects that breadth and the methodological spread it produces. One research stream values the global dimethicone market at USD 696 million in 2025, rising to USD 814 million by 2032 at a 2.3% CAGR, with volume at 278.22 KMT in 2025 growing to 373.90 KMT by 2035 at 3.00%. A broader scope places the 2025 market at USD 4.43 billion, reaching USD 7.27 billion by 2036 at 4.6%. The direction is consistent even where the magnitude is not: moderate volume growth, with value growth driven by the migration of dimethicone from a skin-feel ingredient into medical-grade, electronic and barrier-function applications. For buyers, the defining commercial variable is viscosity. Dimethicone is not a single specification but a family of grades, and the viscosity a supplier can hold within lot-to-lot tolerance determines whether the material performs as a barrier, a conditioner, a release agent or a dielectric fluid.
Core Application Fields and Demand Architecture
Dimethicone demand concentrates in four functional arenas where its silicone backbone delivers performance that hydrocarbon, ester and vegetable-oil alternatives cannot replicate at equivalent stability and sensory profile: personal care and cosmetics, pharmaceutical and medical applications, industrial release and lubrication, and electronic and textile protection.
In personal care and cosmetics, dimethicone is the most widely used silicone-based ingredient, functioning as a skin-conditioning agent, hair-conditioning agent and viscosity-increasing agent. In skincare it forms a breathable barrier that reduces transepidermal water loss without the occlusive weight of petrolatum, and it delivers the slip and spreadability that formulators rely on in primers, foundations and sunscreens. In hair care it reduces combing force, controls frizz and adds shine without the build-up associated with heavier conditioning agents. The segment is not marginal: dimethicone constitutes an estimated 30–40% of cosmetic formulations by function, and the global personal care market, valued above USD 250 billion in 2024, continues to expand at roughly 5% CAGR, directly pulling dimethicone demand. Low-viscosity grades in the 20–350 cSt range dominate facial and body care, while higher-viscosity and elastomer-blended grades serve long-wear and texture-driven formats. The commercial risk in this segment is not demand but regulatory: the same cyclosiloxane residues that can accompany dimethicone are under restriction in the EU, and cosmetic buyers increasingly require documentation that D4, D5 and D6 remain below the applicable thresholds.
In pharmaceutical and medical applications, dimethicone serves as a barrier cream base, an antiflatulent active, a lubricant for syringes and medical devices, and a protective coating for topical and transdermal systems. Medical-grade dimethicone is being integrated into chronic wound-care bandages for its non-allergenic, moisture-locking profile, and transdermal drug-delivery patches are being developed with dimethicone matrices. The regulatory floor here is compendial and, for device and wound-care uses, increasingly defined by medical-grade purity and biocompatibility documentation. Compendial dimethicone is a distinct commercial tier from cosmetic-grade fluid, and suppliers without the viscosity-specific monograph data and heavy-metal documentation cannot serve it.
In industrial release and lubrication, dimethicone functions as a mould-release agent, a lubricant for plastics and elastomers, a antifoam and a surface-treatment agent. Its thermal stability and non-corrosive character support use in automotive, furniture and metal-polishing applications, and in aerospace sealants and insulation where conventional organic lubricants degrade. These applications are less sensitive to sensory profile than personal care, but they demand consistent viscosity and low volatility, because a release agent that leaves residue or a lubricant that volatilizes under heat fails its function.
Electronic and textile applications complete the demand base. In electronics, dimethicone serves as a dielectric cooling fluid and insulating material, and the shift toward electric vehicles is increasing demand for thermal-management fluids where dimethicone’s stability, insulation properties and compatibility with electronic components are valued. In textiles, it is used as a softener, water repellent, hand-feel modifier and sewing-thread lubricant. These segments are smaller in volume than personal care but carry higher specification intensity and, in the electronic case, a growth trajectory tied to electrification rather than to consumer spending cycles.
Regulatory Profile: A Non-CMR Polymer Defined by Cyclosiloxane Residues and Compendial Specificity
Dimethicone is not classified as a carcinogen, mutagen or reproductive toxicant, and it is not on the SVHC Candidate List in its polymeric form. Its regulatory identity is instead defined by two things: the cyclic siloxane residues that can accompany it, and the compendial monographs that govern its pharmaceutical use. This shape is different from the solvent and monomer profiles reviewed elsewhere in this series, and it determines which suppliers can serve which accounts.
In the European Union, dimethicone is a polymer and is exempt from REACH registration, but D4 (octamethylcyclotetrasiloxane), D5 (decamethylcyclopentasiloxane) and D6 (dodecamethylcyclohexasiloxane) are SVHCs and are restricted under REACH Annex XVII entry 70. From 6 June 2026, D4, D5 and D6 cannot be placed on the market as substances, as constituents of other substances, or in mixtures at concentrations ≥0.1% (1,000 mg/kg), subject to specific derogations. Cosmetic products have an extended transition to 6 June 2027, while wash-off cosmetics have been subject to D4/D5 limits since 2020, and medical devices and medicinal products have a transition to 2031. Dimethicone itself is not banned; the restriction targets the cyclic residues. A supplier serving EU cosmetic or pharmaceutical customers must therefore document that residual D4/D5/D6 in the dimethicone lot sit below the relevant threshold, and stripping under heat and vacuum is the standard route to achieving residual cyclosiloxane levels below 0.1%.
In the United States, dimethicone is on the TSCA Inventory and is approved by FDA for cosmetic and pharmaceutical use. The USP–NF monograph defines the compendial specification: dimethicone is a mixture of fully methylated linear siloxane polymers with a nominal viscosity in a discrete range between 20 and 30,000 centistokes, containing not less than 97.0% and not more than 103.0% polydimethylsiloxane, with viscosity, specific gravity, refractive index and loss on heating specified by grade. The monograph also distinguishes dimethicone intended for coating containers that contact parenteral articles, and it requires labelling of the nominal viscosity. For cosmetic use, the CIR safety assessment supports dimethicone, methicone and substituted-methicone polymers as used in cosmetics, with typical cosmetic fluids in the 100 and 350 cSt range. The practical consequence for buyers is that “dimethicone” is not a sufficient purchase specification: the viscosity grade and the intended use category (cosmetic, compendial non-parenteral, parenteral-contact) determine which documentation package is required.
In Russia and the EAEU, dimethicone is supplied as an imported pharmaceutical excipient and cosmetic ingredient. The Russian pharmacopoeia includes a dimethicone monograph (FS.2.1.0310) that sets viscosity-dependent requirements and specifies that dimethicones with a nominal viscosity of 50 mm²/s or lower are intended for external use only. There is no large-scale domestic dimethicone production of compendial grade, and Russian buyers depend on imported material, with China a significant source of silicone imports into Russia. The compliance task is therefore twofold: verify viscosity-specific compendial compliance and secure Russian-language safety documentation for the grade in question.
Global Supply Structure and Manufacturer Differentiation
Global dimethicone supply is moderately concentrated and structured around silicone-integrated producers with upstream siloxane chemistry. The two largest players, Dow (including the historical Dow Corning silicones business) and Wacker Chemie, together hold approximately 35% of the global market, with the remaining share distributed among Momentive, Shin-Etsu, KCC Basildon, NuSil and a cohort of Chinese producers including Wynca, Dongyue, Tinci and others. Europe and North America together account for roughly 50% of global consumption, reflecting the concentration of cosmetic, pharmaceutical and industrial silicone demand in those regions.
Differentiation operates on three axes that are more technical than commercial. The first is viscosity control across the grade range. Dimethicone is supplied as low-, medium- and high-viscosity fluids, with medium-viscosity grades holding approximately 65% of the market. Each viscosity band serves a distinct function: 20–50 cSt fluids for spreading and sensory lightness, 100–1,000 cSt for barrier and conditioning performance, and high-viscosity or gum grades for release, damping and elastomer applications. A supplier that can hold a nominal viscosity within a narrow tolerance, and document that tolerance on a certificate of analysis, reduces the reformulation risk that arises when a lot drifts outside the validated sensory or functional window. The second axis is residual cyclosiloxane control. As the EU restriction moves into force, the ability to supply dimethicone with documented low D4/D5/D6 content becomes a qualification requirement for European cosmetic and pharmaceutical accounts, not a premium feature. Suppliers using thin-film or vacuum stripping can consistently reach residual cyclosiloxane levels below the 0.1% threshold, while suppliers without that capability face progressive exclusion from EU-facing supply chains. The third axis is compendial and application-specific documentation. Cosmetic-grade fluid, USP–NF non-parenteral dimethicone and parenteral-contact dimethicone each carry different documentation expectations, and medical-device and wound-care applications add biocompatibility and traceability requirements. In a market where the polymer is the same but the qualification burden differs by grade, documentation depth is a genuine differentiator.
For Russian and EAEU buyers, the supply structure creates a specific dependency. Domestic production of compendial dimethicone is limited, imports are dominated by Chinese and, to a lesser extent, European and Korean material, and the buyer must bridge the gap between the supplier’s certificate of analysis and the Russian pharmacopoeial monograph. This is the context in which a supplier with viscosity-specific documentation, Russian-language SDS and a clear statement of residual cyclosiloxane content becomes more valuable than a low-cost spot offer.
Regional Demand Dynamics
Dimethicone demand is regionally asymmetric in a way that follows the geography of cosmetic and pharmaceutical manufacturing rather than the geography of silicone production.
Europe and North America together account for approximately half of global dimethicone consumption and set the specification bar for the rest of the market. Europe’s demand is shaped by the D4/D5/D6 restriction: cosmetic and pharmaceutical buyers are actively requalifying suppliers on residual cyclosiloxane documentation, and the 2026–2027 compliance deadlines are converting that documentation from a differentiator into a condition of market access. North America’s demand is anchored in a mature personal care market, a large pharmaceutical excipient base, and growing medical-grade applications in wound care and transdermal delivery. Both regions are growing at low-to-mid single digits in volume, with value growth driven by medical-grade and high-performance segments rather than by commodity fluid.
Asia-Pacific is the faster-growing region, supported by cosmetic and personal care expansion in China, Japan, South Korea and Southeast Asia, by pharmaceutical manufacturing growth, and by the build-out of electronic and electric-vehicle supply chains that require dielectric and thermal-management fluids. China is both a large consumer and a significant exporter of dimethicone, and its domestic producers are increasingly capable across the viscosity range, though the compendial and medical-grade tiers remain qualification-intensive. The region’s demand is bifurcated between price-sensitive industrial and textile applications and documentation-sensitive cosmetic and pharmaceutical applications, and the gap between those tiers is widening as regulatory requirements tighten.
Russia and the EAEU form an import-dependent contour. Domestic dimethicone production does not cover compendial or cosmetic-grade demand, and imports from China, Europe and South Korea supply the market. Demand is concentrated in cosmetics and personal care, pharmaceutical excipients and industrial applications, with medical-grade and electronic-grade volumes smaller but growing. The practical consequence for Russian buyers is that supplier selection must carry the full documentation burden: viscosity-specific compendial compliance, Russian-language SDS, and a clear statement of residual cyclosiloxane content for cosmetic applications.
Future Outlook and Strategic Imperatives
The dimethicone market will grow at a moderate rate in volume—low-to-mid single digits depending on scope—but the quality of that growth is shifting toward applications where dimethicone is functionally decisive rather than merely formulary.
Three structural forces will shape competition. First, the D4/D5/D6 restriction is redefining the supplier qualification bar in Europe. The 2026 mixture limit and the 2027 cosmetic deadline mean that residual cyclosiloxane control is moving from a technical nicety to a market-access condition, and suppliers that can document low residuals will be preferred over those that cannot, even at a price premium. Second, medical-grade and electronic-grade applications are pulling dimethicone into higher-value, specification-intensive segments. Wound care, transdermal delivery, electric-vehicle thermal management and aerospace sealants all demand viscosity consistency, purity and documentation depth that commodity cosmetic fluid does not require, and they are growing faster than the personal care base. Third, the industry is moving toward closed-loop and lower-impact silicone manufacturing, with producers investing in siloxane recovery and renewable feedstocks in response to REACH, California Proposition 65 and B2B ESG requirements. Sustainability documentation will become a parallel qualification axis to technical documentation.
For Russian and EAEU buyers, the strategic implication is that dimethicone procurement should be treated as a viscosity-and-documentation partnership rather than a spot purchase. A failed lot—whether from viscosity drift, an incomplete compendial dossier or a residual cyclosiloxane result that fails a customer audit—does not simply cost the price of the drum; it can invalidate a cosmetic batch, delay a pharmaceutical registration or force a reformulation. The lowest-risk supplier is the one that can match the viscosity grade to the application, document compendial compliance against the relevant monograph, provide Russian-language SDS, and state residual D4/D5/D6 content with lot-level data.
Shanghai XinChem Co., Ltd. (XinChem)
As a world-leading supplier of organic chemicals, Shanghai XinChem Co., Ltd. (XinChem) offers dimethicone (CAS 63148-62-9) in cosmetic-grade and compendial specifications across a broad viscosity range, serving personal care formulators, pharmaceutical excipient buyers, industrial release and lubrication users, and electronic and textile processors. Our dimethicone is supplied with controlled nominal viscosity, documented residual cyclosiloxane content and lot-to-lot consistency, supported by the analytical documentation and Russian-language SDS that cosmetic, compendial and application-specific qualification requires.
Technical and Quality Advantages
Viscosity-Specific Control and Documentation: Dimethicone performance is determined by nominal viscosity, not by a generic “silicone fluid” label. XinChem supplies material against defined viscosity windows—from low-viscosity fluids for sensory-light personal care to medium- and high-viscosity grades for barrier, release and conditioning applications—with the viscosity result documented on the certificate of analysis so that the buyer can match the grade to the validated formulation rather than treating viscosity as an uncontrolled variable.
Residual Cyclosiloxane Management: For EU-facing cosmetic and pharmaceutical applications, the D4/D5/D6 content is controlled and documented against the applicable REACH Annex XVII threshold, with stripping technology used to achieve residual cyclosiloxane levels consistent with the 0.1% mixture limit. This is the specification set that determines whether a cosmetic-grade lot can enter a European supply chain after the 2026–2027 compliance deadlines.
Compendial Coverage: Dimethicone is supplied against the USP–NF monograph where compendial qualification is required, with certificate-of-analysis data covering polydimethylsiloxane content (97.0–103.0%), viscosity, refractive index, specific gravity and loss on heating. The documentation package supports non-parenteral and parenteral-contact qualification where the intended use requires it.
Regulatory and Language Support: Safety data sheets and technical documentation are available in English and Russian, with regulatory tracking of REACH Annex XVII entry 70, cosmetic transition deadlines and pharmacopoeial monograph revisions. Buyers receive advance notice of changes that could affect viscosity specification, residual cyclosiloxane limits or labelling.
Packaging and Logistics Flexibility
Dimethicone is available in 200 kg drums and IBCs for industrial and personal care volumes, and in sealed 1 kg and 5 kg containers for pilot, laboratory and qualification quantities. For Russia and EAEU destinations, XinChem arranges logistics with appropriate customs and transport documentation, including Russian-language SDS and certificate-of-analysis support, to reduce clearance friction for a product that is already import-dependent in the region.
Application Support and Supply Reliability
XinChem’s technical team assists with grade selection for skin barrier and sensory applications, hair conditioning, pharmaceutical barrier creams and antiflatulent uses, release and lubrication systems, and dielectric and thermal-management fluids, and with the residual cyclosiloxane and viscosity documentation that cosmetic and compendial qualification demands. Supply schedules accommodate both qualification lots and recurring contract volumes, with safety stock held to buffer the concentration of global silicone capacity and freight variability on Asia–Russia and Asia–Europe lanes.
Why Choose XinChem
Expertise: Deep experience in silicone polymers and functional formulation ingredients, with application knowledge spanning personal care, pharmaceutical excipients, industrial release and electronic protection.
Consistency: Control of nominal viscosity and residual cyclosiloxane content—the parameters that determine whether dimethicone delivers the intended feel, barrier or dielectric function, or becomes a reformulation problem.
Compliance Readiness: Documentation structured around the USP–NF monograph, REACH Annex XVII entry 70 and the EU cosmetic transition deadlines, with Russian-language SDS and lot-level viscosity and cyclosiloxane data.
Responsiveness: Direct technical and commercial access, with order structures from qualification quantities to contract volumes.
Contact us now to discuss your dimethicone requirements and request a specification sheet or qualification sample.
Website: www.xinchem.com
Email: sales1@xinchem.com
WhatsApp: +86 18049800532
Post time: Oct-25-2026